Unibios Holdings S.A
Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment and recycling systems in Europe, Africa, and the Middle East. It provides installation and rental of faced scaffolding; and maintains and installs heating and air conditioning equipment. The company was formerly known as Biossol SA and changed its name to Unibios Holdings S.A. in July 2008. Unibios Holdings S.A… Read more
Unibios Holdings S.A (BIOSK) - Total Liabilities
Latest total liabilities as of December 2024: €11.66 Million EUR
Based on the latest financial reports, Unibios Holdings S.A (BIOSK) has total liabilities worth €11.66 Million EUR as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Unibios Holdings S.A - Total Liabilities Trend (2014–2024)
This chart illustrates how Unibios Holdings S.A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Unibios Holdings S.A Competitors by Total Liabilities
The table below lists competitors of Unibios Holdings S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Omega Oil & Gas Ltd
AU:OMA
|
Australia | AU$2.83 Million |
|
Thai Metal Drum Manufacturing Public Company Limited
BK:TMD
|
Thailand | ฿270.73 Million |
|
Pan-Pacific
KO:007980
|
Korea | ₩491.22 Billion |
|
Forge Resources Corp.
OTCQB:FRGGF
|
USA | $3.71 Million |
|
Neogrid Participações S.A
SA:NGRD3
|
Brazil | R$135.18 Million |
|
HBL Corporation
KQ:452190
|
Korea | ₩8.68 Billion |
|
Shin Nippon Biomedical Laboratories, Ltd.
PINK:SBLOF
|
USA | $52.75 Billion |
|
KAISA GROUP HLDGS
F:KG5
|
Germany | €244.45 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Unibios Holdings S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Unibios Holdings S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Unibios Holdings S.A (2014–2024)
The table below shows the annual total liabilities of Unibios Holdings S.A from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €11.66 Million | +8.46% |
| 2023-12-31 | €10.75 Million | -12.99% |
| 2022-12-31 | €12.36 Million | +14.53% |
| 2021-12-31 | €10.79 Million | -4.08% |
| 2020-12-31 | €11.25 Million | +13.76% |
| 2019-12-31 | €9.89 Million | -17.56% |
| 2018-12-31 | €11.99 Million | +11.53% |
| 2017-12-31 | €10.75 Million | +9.99% |
| 2016-12-31 | €9.78 Million | -14.10% |
| 2015-12-31 | €11.38 Million | -5.40% |
| 2014-12-31 | €12.03 Million | -- |